Stonehage Fleming Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Stonehage Fleming Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-400	Closed	-$4K	–	196
2019 Q4	$4K	Sell	400 -8,325	-95%	-$74.3K	﹤0.01%	185
2019 Q3	$60K	Hold	8,725	–	–	﹤0.01%	151
2019 Q2	$81K	Hold	8,725	–	–	﹤0.01%	144
2019 Q1	$137	Hold	8,725	–	–	0.01%	146
2018 Q4	$135K	Hold	8,725	–	–	0.01%	176
2018 Q3	$188K	Hold	8,725	–	–	0.01%	169
2018 Q2	$212K	Hold	8,725	–	–	0.01%	167
2018 Q1	$149K	Sell	8,725 -9,310	-52%	-$182K	0.01%	171
2017 Q4	$342K	Hold	18,035	–	–	0.02%	147
2017 Q3	$317K	Sell	18,035 -4,400	-20%	-$99K	0.02%	159
2017 Q2	$745K	Buy	22,435 +8,650	+63%	+$268K	0.05%	109
2017 Q1	$442K	Sell	13,785 -17,554	-56%	-$599K	0.03%	172
2016 Q4	$1.14M	Sell	31,339 -4,233	-12%	-$169K	0.07%	117
2016 Q3	$1.64M	Buy	35,572 +5,050	+17%	+$263K	0.1%	93
2016 Q2	$1.53M	Buy	30,522 +2,527	+9%	+$135K	0.1%	94
2016 Q1	$1.5M	Buy	+27,995	New	+$1.64M	0.1%	93

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Stonehage Fleming Financial Services's TEVA Position: Q1 2020 in Review

Stonehage Fleming Financial Services sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 400 shares — an estimated $4K sold.

Stonehage Fleming Financial Services first reported a position in TEVA in Q1 2016 and held it in 16 quarters. The position peaked at $1.64M in Q3 2016. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

Stonehage Fleming Financial Services reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Stonehage Fleming Financial Services sold 400 Teva Pharmaceuticals shares in Q1 2020, an estimated $4K.
Stonehage Fleming Financial Services first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 16 quarters.
Stonehage Fleming Financial Services's Teva Pharmaceuticals position peaked at $1.64M in Q3 2016.
459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Stonehage Fleming Financial Services's 13F filing for Q1 2020, filed 13 May 2020.